Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients

(2012) Sandeep S. Patil et al.   Journal of Translational Medicine

Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection

(2011) Stephanie Weibel et al.   BMC CANCER

Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice

(2011) M Gil et al.   BRITISH JOURNAL OF CANCER

Tumor-Associated Neutrophils: New Targets for Cancer Therapy

(2011) A. D. Gregory et al.   CANCER RESEARCH

Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice

(2011) Nanhai G Chen et al.   Journal of Translational Medicine

Polymerase chain reaction–based species verification and microsatellite analysis for canine cell line validation

(2011) Liza E. O’Donoghue et al.   JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION

Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68

(2011) Ivaylo Gentschev et al.   PLoS One

Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA

(2010) C M Seubert et al.   CANCER GENE THERAPY

Regression of Human Prostate Tumors and Metastases in Nude Mice following Treatment with the Recombinant Oncolytic Vaccinia Virus GLV-1h68

(2010) Ivaylo Gentschev et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Establishment and Characterization of a Canine Soft Tissue Sarcoma Cell Line

(2010) S. A. Snyder et al.   VETERINARY PATHOLOGY

Prognostic Factors for Cutaneous and Subcutaneous Soft Tissue Sarcomas in Dogs

(2010) M. M. Dennis et al.   VETERINARY PATHOLOGY

Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68

(2010) Ivaylo Gentschev et al.   Journal of Oncology

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

(2009) Zvi G. Fridlender et al.   CANCER CELL

The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon

(2009) Robin J. Prestwich et al.   HUMAN GENE THERAPY

Oncolytic vaccinia therapy of squamous cell carcinoma

(2009) Zhenkun Yu et al.   Molecular Cancer

Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68

(2009) Y. A. Yu et al.   MOLECULAR CANCER THERAPEUTICS

The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation

(2009) Qian Zhang et al.   MOLECULAR GENETICS AND GENOMICS

Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks

(2009) M. Arendt et al.   Veterinary and Comparative Oncology

Histologic Grade Predicts Recurrence for Marginally Excised Canine Subcutaneous Soft Tissue Sarcomas

(2009) K. D. McSporran   VETERINARY PATHOLOGY

Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent

(2008) I Gentschev et al.   CANCER GENE THERAPY

Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment

(2008) Stephanie Weibel et al.   CELLULAR MICROBIOLOGY

Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma

(2008) Kaitlyn J. Kelly et al.   HUMAN GENE THERAPY

Real-time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV-1h68 in an immunocompetent animal model

(2008) Kaitlyn J. Kelly et al.   INTERNATIONAL JOURNAL OF CANCER

Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancerin Vivo

(2008) Shu-Fu Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM